AU2003260793A8 - Therapeutic compositions comprising a boron-containing compound - Google Patents

Therapeutic compositions comprising a boron-containing compound

Info

Publication number
AU2003260793A8
AU2003260793A8 AU2003260793A AU2003260793A AU2003260793A8 AU 2003260793 A8 AU2003260793 A8 AU 2003260793A8 AU 2003260793 A AU2003260793 A AU 2003260793A AU 2003260793 A AU2003260793 A AU 2003260793A AU 2003260793 A8 AU2003260793 A8 AU 2003260793A8
Authority
AU
Australia
Prior art keywords
boron
containing compound
therapeutic compositions
therapeutic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003260793A
Other versions
AU2003260793A1 (en
Inventor
Bipin Patel
Ken Rickwood
Ian Flockhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psimei Pharmaceuticals PLC
Original Assignee
Psimei Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimei Pharmaceuticals PLC filed Critical Psimei Pharmaceuticals PLC
Publication of AU2003260793A1 publication Critical patent/AU2003260793A1/en
Publication of AU2003260793A8 publication Critical patent/AU2003260793A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
AU2003260793A 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound Abandoned AU2003260793A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0222945.8 2002-10-03
GBGB0222945.8A GB0222945D0 (en) 2002-10-03 2002-10-03 Therapeutic compositions
PCT/GB2003/003870 WO2004030661A2 (en) 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound

Publications (2)

Publication Number Publication Date
AU2003260793A1 AU2003260793A1 (en) 2004-04-23
AU2003260793A8 true AU2003260793A8 (en) 2004-04-23

Family

ID=9945241

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003260793A Abandoned AU2003260793A1 (en) 2002-10-03 2003-09-05 Therapeutic compositions comprising a boron-containing compound

Country Status (3)

Country Link
AU (1) AU2003260793A1 (en)
GB (1) GB0222945D0 (en)
WO (1) WO2004030661A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863484B1 (en) * 2003-12-11 2007-04-13 Oreal USE OF COMPOUNDS CAPABLE OF ACTING ON THE METABOLIC PATHWAY CONTROLLED BY DOPACHROME TAUTOMERASE TRP-2 AS PROTECTIVE AGENT OF MELANOCYTES OF FOLLICLE AND APPLICATIONS
GB0404708D0 (en) * 2004-03-02 2004-04-07 Cellic As T Boron containing nanoparticles
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8287839B2 (en) 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
CN110678515B (en) 2017-04-07 2023-03-14 北卡罗莱纳州立大学 Additive for fiber reinforcement
CN111117124B (en) * 2018-10-30 2021-02-12 华南理工大学 Hot water soluble polyvinyl alcohol film and preparation method and application thereof
KR102562968B1 (en) * 2018-11-01 2023-08-04 주식회사 셀비온 p-Boronophenylalanine composition for Boron Neutron Capture Therapy and preparing method thereof
CN116270504A (en) * 2019-04-26 2023-06-23 南京中硼联康医疗科技有限公司 BPA freeze-dried preparation and preparation method thereof
AU2020345320A1 (en) * 2019-09-12 2022-04-14 Stella Pharma Corporation Method for preventing precipitation of injectable solution containing p-boronophenylalanine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5581010A (en) * 1994-07-22 1996-12-03 Rockwell International Corporation Semi-organic crystals for nonlinear optical devices
US6169076B1 (en) * 1999-03-31 2001-01-02 Glcosyn Pharmaceuticals, Inc. P-Boronophenylalanine complexes with fructose and related carbohydrates and polyols

Also Published As

Publication number Publication date
WO2004030661A2 (en) 2004-04-15
AU2003260793A1 (en) 2004-04-23
GB0222945D0 (en) 2002-11-13
WO2004030661A3 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
IL166156A0 (en) Boroproline compound combination therapy
GB0217225D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0225535D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0225030D0 (en) Medicinal compounds
HK1092155A1 (en) A bisfluorenylsilane compound
AU2003260793A8 (en) Therapeutic compositions comprising a boron-containing compound
PL397821A1 (en) 1-acetyl-6-fluoro-2-indolinone compound
AU2003215150A8 (en) Therapeutic compounds
GB0204241D0 (en) Compound
AU2003282722A8 (en) Therapeutic compositions
GB0224830D0 (en) Compound
AU2003222571A8 (en) Novel therapeutic application for a composition
GB0213027D0 (en) Compound
GB0208392D0 (en) Therapeutic compounds
GB0200815D0 (en) Analgesic compositions
GB0228652D0 (en) Therapeutic compositions
GB0228227D0 (en) Therapeutic compositions
GB0226830D0 (en) Composition for use as a medicament
GB0200135D0 (en) Therapeutic Compounds
GB0200136D0 (en) Therapeutic compounds
GB0201509D0 (en) Therapeutic Compounds
GB0219721D0 (en) Therapeutic compounds
GB0200134D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase